Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS, Revenue Beat Expectations
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 adjusted EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $213 million versus the consensus estimate of $208.98 million.